New treatments aim to lengthen remissions and push back recurrences.

by Erin O’Donnell

Antibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.

by Kendall K. Morgan

Healthy Habits

Drinking sugar-sweetened beverages contributes to excess body fat and increased risk for certain cancers.

by Anne Danahy

Healthy Habits

New research suggests compression and cold therapy may limit chemotherapy-induced peripheral neuropathy.

by Tyler Santora

Forward Look

Hematologist-oncologist Saad Usmani talks about recent approvals for bispecific antibodies to treat multiple myeloma and other blood cancers.

by Ashley P. Taylor

Forward Look

New oral hormonal therapy offers alternative to injections for some women with metastatic disease.

by Kris Conner

Forward Look

Adoptive T-cell therapy shows promise in treating metastatic melanoma.

by Marci A. Landsmann

Lesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.

by Jon Kelvey

Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.

by Kyle Bagenstose

People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment options.

by Marci A. Landsmann